139 related articles for article (PubMed ID: 3101340)
1. Growth hormone response to growth hormone-releasing hormone in normal and uraemic children. Comparison with hypoglycaemia following insulin administration.
Bessarione D; Perfumo F; Giusti M; Ginevri F; Mazzocchi G; Gusmano R; Giordano G
Acta Endocrinol (Copenh); 1987 Jan; 114(1):5-11. PubMed ID: 3101340
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients.
Tokgöz B; Utaş C; Dogukan A; Güven M; Taşkapan H; Oymak O; Keleştimur F
Perit Dial Int; 2001; 21(5):448-54. PubMed ID: 11757827
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
4. Atropine selectively blocks GHRH-induced GH secretion without altering LH, FSH, TSH, PRL and ACTH/cortisol secretion elicited by their specific hypothalamic releasing factors.
Casanueva FF; Villanueva L; Diaz Y; Devesa J; Fernandez-Cruz A; Schally AV
Clin Endocrinol (Oxf); 1986 Sep; 25(3):319-23. PubMed ID: 3024879
[TBL] [Abstract][Full Text] [Related]
5. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
6. Luteinizing hormone responses to luteinizing hormone releasing hormone, and growth hormone and cortisol responses to insulin induced hypoglycaemia in functional secondary amenorrhoea.
Hirvonen E; Seppälä M; Karonen SL; Adlercreutz H
Acta Endocrinol (Copenh); 1977 Feb; 84(2):225-36. PubMed ID: 319613
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I
Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin.
Díez JJ; Sastre J; Iglesias P; Selgas R; Romero JR; Méndez J; Gómez-Pan A
Adv Perit Dial; 1992; 8():340-5. PubMed ID: 1361819
[TBL] [Abstract][Full Text] [Related]
9. Hormonal changes induced by a partial opiate antagonist, nalorphine. Evaluation of PRL, GH, TSH, LH, FSH and cortisol secretion.
Rolandi E; Magnani G; Sannia A; Barreca T
Eur J Clin Pharmacol; 1981; 21(1):23-5. PubMed ID: 6800826
[TBL] [Abstract][Full Text] [Related]
10. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
Tokgöz B; Utaş C; Doğukan A; Oymak O; Keleştimur F
Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
[TBL] [Abstract][Full Text] [Related]
11. Combined test of hypothalamic-pituitary function in growth-retarded children treated with growth hormone. II. Secretion of LH, FSH, TSH, prolactin and ACTH.
Eskildsen PC; Jacobsen BB; Kastrup KW; Krabbe S; Lebech PE; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():14-20. PubMed ID: 232353
[TBL] [Abstract][Full Text] [Related]
12. Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients.
Díez JJ; Iglesias P; Aguilera A; Bajo MA; Selgas R
Nephrol Dial Transplant; 1999 Jul; 14(7):1704-9. PubMed ID: 10435880
[TBL] [Abstract][Full Text] [Related]
13. Theophylline blunts the GH-response to growth hormone releasing hormone in normal subjects.
Losa M; Huss R; König A; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1986 Aug; 112(4):473-80. PubMed ID: 3092529
[TBL] [Abstract][Full Text] [Related]
14. [Global pituitary stimulation test with releasing hormones].
Holl R; Fehm HL; Hetzel WD; Heinze E; Voigt KH
Dtsch Med Wochenschr; 1985 Jun; 110(24):953-5. PubMed ID: 2986936
[TBL] [Abstract][Full Text] [Related]
15. Altered growth hormone response after growth hormone releasing hormone administration in chronic renal failure.
Garcia RV; Andrade A; Perez J; Courel M; Casanueva FF
J Endocrinol Invest; 1991 May; 14(5):383-9. PubMed ID: 1908493
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone and cortisol secretion before and after erythropoietin therapy in CAPD patients.
Diez JJ; Iglesias P; Sastre J; Gomez-Pan A; Mendez J; Bajo MA; Selgas R
Adv Perit Dial; 1994; 10():275-81. PubMed ID: 7999845
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of insulin- and proinsulin-induced hypoglycemia on pituitary hormone and catecholamine secretion.
Williams TC; Berelowitz M; Berk MA; Frohman LA
Diabetes Care; 1987; 10(3):278-85. PubMed ID: 3109862
[TBL] [Abstract][Full Text] [Related]
18. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
19. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
Vance ML; Borges JL; Kaiser DL; Evans WS; Furlanetto R; Thominet JL; Frohman LA; Rogol AD; MacLeod RM; Bloom S
J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660
[TBL] [Abstract][Full Text] [Related]
20. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
Jeppsson S; Nilsson KO; Rannevik G; Wide L
Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
